A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia

Chest

Volumn 147, Issue 6, 2015, Pages 1494-1502

  May, Addison K ^a   Brady, Jacob S ^a   Romano Keeler, Joann ^a   Drake, Wonder P ^a   Norris, Patrick R ^a   Jenkins, Judith M ^a   Isaacs, Richard J ^b   Boczko, Erik M ^c  

^a VANDERBILT UNIVERSITY   (United States)

^b Molecular Sensing Inc   (United States)

^c OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DNA 16S;

ACINETOBACTER BAUMANNII; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; COLONY FORMING UNIT S; EARLY DIAGNOSIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXHALED BREATH CONDENSATE FLUID; HEAT AND MOISTURE EXCHANGER FILTER; HUMAN; HUMIDIFI AND MOISTURE EXCHANGER FILTER; KLEBSIELLA PNEUMONIAE; LUNG FLUID; LUNG LAVAGE; MEDICAL DEVICE; NON INVASIVE PROCEDURE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; COMPARATIVE STUDY; CRITICAL ILLNESS; DEVICES; DIAGNOSTIC TEST; EXHALATION; GENETICS; INTENSIVE CARE UNIT; LUNG; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROFLORA; PILOT STUDY; PNEUMONIA, VENTILATOR-ASSOCIATED; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS;

BRONCHOALVEOLAR LAVAGE; CRITICAL ILLNESS; DIAGNOSTIC TESTS, ROUTINE; DNA, BACTERIAL; EXHALATION; HUMANS; INTENSIVE CARE UNITS; LUNG; MICROBIOLOGICAL TECHNIQUES; MICROBIOTA; PILOT PROJECTS; PNEUMONIA, VENTILATOR-ASSOCIATED; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84930907563     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1687     Document Type: Article

References (58)

1. Minei JP, Nathens AB, West M, et al; Inflammation and the Host Response to Injury Large Scale Collaborative Research Program Investigators. Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core - standard operating procedures for clinical care. II. Guidelines for prevention, diagnosis and treatment of ventilator-associated pneumonia (VAP) in the trauma patient. J Trauma. 2006;60(5):1106-1113.
2. Rello J, Ollendorf DA, Oster G, et al; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115-2121.
3. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33(10):2184-2193.
4. Cavalcanti M, Ferrer M, Ferrer R, Morforte R, Garnacho A, Torres A. Risk and prognostic factors of ventilatorassociated pneumonia in trauma patients. Crit Care Med. 2006;34(4):1067-1072.
5. Cook DJ, Kollef MH. Risk factors for ICU-acquired pneumonia. JAMA. 1998;279(20):1605-1606.
6. Croce MA, Tolley EA, Fabian TC. A formula for prediction of posttraumatic pneumonia based on early anatomic and physiologic parameters. J Trauma. 2003;54(4):724-729.
7. Evans HL, Warner K, Bulger EM, Sharar SR, Maier RV, Cuschieri J. Pre-hospital intubation factors and pneumonia in trauma patients. Surg Infect (Larchmt). 2011;12(5):339-344.
8. Lockey DJ, Coats T, Parr MJ. Aspiration in severe trauma: a prospective study. Anaesthesia. 1999;54(11):1097-1098.
9. Rea-Neto A, Youssef NC, Tuche F, et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 2008;12(2):R56.
10. Croce MA, Fabian TC, Schurr MJ, et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis. J Trauma. 1995;39(6):1134-1139.
11. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilatorassociated pneumonia. A randomized trial. Ann Intern Med. 2000;132(8):621-630.
12. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 1994;106(1):221-235.
13. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest. 2005;127(2):589-597.
14. Croce MA, Swanson JM, Magnotti LJ, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma. 2006;60(3):523-527.
15. Fartoukh M, Maitre B, Honoré S, Cerf C, Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med. 2003;168(2):173-179.
16. Lauzier F, Ruest A, Cook D, et al; Canadian Critical Care Trials Group. The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care. 2008;23(1):50-57.
17. Luyt CE, Chastre J, Fagon JY. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004;30(5):844-852.
18. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and interobserver variability. Intensive Care Med. 2004;30(2):217-224.
19. Minshall CT, Eriksson EA, Hawkins KS, Wolf S, Minei JP. Early nonbronchoscopic bronchoalveolar lavage: predictor of ventilator-associated pneumonia? J Trauma Acute Care Surg. 2013;74(2):448-452.
20. Alvarez-Lerma F; ICU-Acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 1996;22(5):387-394.
21. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31(suppl 4):S131-S138.
22. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111(3):676-685.
23. Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156(1):196-200.
24. Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt). 2005;6(1):41-54.
25. Fabian TC, Croce MA, Payne LW, Minard G, Pritchard FE, Kudsk KA. Duration of antibiotic therapy for penetrating abdominal trauma: a prospective trial. Surgery. 1992;112(4):788-794.
26. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916-2921.
27. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA. 1993;270(16):1965-1970.
28. May AK, Fleming SB, Carpenter RO, et al. Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in headinjured patients. Surg Infect (Larchmt). 2006;7(5):409-417.
29. Namias N, Harvill S, Ball S, McKenney MG, Salomone JP, Civetta JM. Cost and morbidity associated with antibiotic prophylaxis in the ICU. J Am Coll Surg. 1999;188(3):225-230.
30. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157(2):531-539.
31. Velmahos GC, Toutouzas KG, Sarkisyan G, et al. Severe trauma is not an excuse for prolonged antibiotic prophylaxis. Arch Surg. 2002;137(5):537-541.
32. Eames I, Tang JW, Li Y, Wilson P. Airborne transmission of disease in hospitals. J R Soc Interface. 2009;6(suppl 6):S697-S702.
33. Xie X, Li Y, Sun H, Liu L. Exhaled droplets due to talking and coughing. J R Soc Interface. 2009;6(suppl 6):S703-S714.
34. Edmiston CE Jr, Sinski S, Seabrook GR, et al. Airborne particulates in the OR environment. AORN J. 1999;69(6):1169-1172.
35. Edmiston CE Jr, Seabrook GR, Cambria RA, et al. Molecular epidemiology of microbial contamination in the operating room environment: Is there a risk for infection? Surgery. 2005;138(4):573-579.
36. Isaacs RJ, Debelak K, Norris PR, et al. Non-invasive detection of pulmonary pathogens in ventilator-circuit filters by PCR. Am J Transl Res. 2012;4(1):72-82.
37. Carroll KC, Glanz BD, Borek AP, et al. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae. J Clin Microbiol. 2006;44(10):3506-3509.
38. Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broadrange (universal) probe and primers set. Microbiology. 2002;148 (pt 1):257-266.
39. Cherkaoui A, Emonet S, Ceroni D, et al. Development and validation of a modified broad-range 16S rDNA PCR for diagnostic purposes in clinical microbiology. J Microbiol Methods. 2009;79(2):227-231.
40. Gu F, Li Y, Zhou C, et al. Bacterial 16S rRNA/rDNA profiling in the liquid phase of human saliva. Open Dent J. 2009;3:80-84.
41. Horz HP, Vianna ME, Gomes BP, Conrads G. Evaluation of universal probes and primer sets for assessing total bacterial load in clinical samples: general implications and practical use in endodontic antimicrobial therapy. J Clin Microbiol. 2005;43(10):5332-5337.
42. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155-2161.
43. Siala M, Gdoura R, Fourati H, et al. Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis. Arthritis Res Ther. 2009;11(4):R102.
44. Stowers CC, Haselton FR, Boczko EM. An analysis of quantitative PCR reliability through replicates using the C method. J Biomed Sci Eng. 2010;3(5):459-469.
45. Krämer HJ, Schmidt R, Günther A, Becker G, Suzuki Y, Seeger W. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1995;152(5 pt 1):1540-1544.
46. Ivanova PT, Milne SB, Byrne MO, Xiang Y, Brown HA. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Methods Enzymol. 2007;432:21-57.
47. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857-872.
48. Hanley JA. Standard error of the Kappa statistic. Psychol Bull. 1987;102(2):315-321.
49. Bodini A, D'Orazio C, Peroni D, et al. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Pediatr Pulmonol. 2005;40(6):494-499.
50. Effros RM, Dunning MB III, Biller J, Shaker R. The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol. 2004;287(6):L1073-L1080.
51. Hunt J. Exhaled breath condensate: an overview. Immunol Allergy Clin North Am. 2007;27(4):587-596.
52. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med. 2007;175(3):222-227.
53. Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS One. 2008;3(7):e2691.
54. Muscatello G, Gilkerson JR, Browning GF. Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals. J Clin Microbiol. 2009;47(3):734-737.
55. Bahrani-Mougeot FK, Paster BJ, Coleman S, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilatorassociated pneumonia. J Clin Microbiol. 2007;45(5):1588-1593.
56. Rice LM, Reis AH Jr, Mistry R, et al. Design and construction of a single tube, quantitative endpoint, LATE-PCR multiplex assay for ventilatorassociated pneumonia. J Appl Microbiol. 2013;115(3):818-827.
57. Bos LD, Wang Y, Weda H, et al. A simple breath sampling method in intubated and mechanically ventilated critically ill patients. Respir Physiol Neurobiol. 2014;191:67-74.
58. Jünger M, Vautz W, Kuhns M, et al. Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria. Appl Microbiol Biotechnol. 2012;93(6):2603-2614.